More specifically, it is unclear if the ApoE4 effects may still be evident at a stage of AD, when mechanisms of neurodegeneration are most pronounced, e.g., at the stage of mild cognitive impairment (MCI). The gene discussed is APOE; the disease is Alzheimer disease.